These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7779872)

  • 41. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
    Guinet R; Mazoyer MA
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new method of antibiotyping yeasts for subspecies discrimination and distribution in human clinical specimens.
    Quindós G; Lipperheide V; Barturen B; Alonso R; Bikandi J; San Millán R; Tellaetxe M; Ribacoba L; Pontón J
    Eur J Epidemiol; 1996 Feb; 12(1):55-62. PubMed ID: 8817179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serotyping of 48 isolates of Candida albicans: predominance of serotype A over B in Venezuela].
    Mendoza M; Russian E; Villanueva E; de Torres E; de Albornoz MC
    Invest Clin; 1992; 33(1):33-7. PubMed ID: 1391075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro comparison of the activity of various antifungal drugs against new yeast isolates causing thrush in poultry.
    Lin MY; Huang KJ; Kleven SH
    Avian Dis; 1989; 33(3):416-21. PubMed ID: 2673187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
    Siikala E; Richardson M; Pfaller MA; Diekema DJ; Messer SA; Perheentupa J; Saxén H; Rautemaa R
    Int J Antimicrob Agents; 2009 Dec; 34(6):607-9. PubMed ID: 19748230
    [No Abstract]   [Full Text] [Related]  

  • 49. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
    Odds FC; Cheesman SL; Abbott AB
    Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.
    Girish Kumar CP; Hanafy AM; Katsu M; Mikami Y; Menon T
    Mycopathologia; 2006 Mar; 161(3):153-9. PubMed ID: 16482387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses.
    Carvalhinho S; Costa AM; Coelho AC; Martins E; Sampaio A
    Mycopathologia; 2012 Jul; 174(1):69-76. PubMed ID: 22246961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 53. Biotypes, genotypes and ketoconazole susceptibility of Candida albicans isolates from a group of Thai AIDS patients.
    Teanpaisan R; Niyombandith M; Pripatnanant P; Sattayasanskul W
    New Microbiol; 2008 Jul; 31(3):409-16. PubMed ID: 18843897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Routine application of the evaluation of yeasts susceptibility to the main antimycotic drugs.
    Lombardi G; Cavanna C; Gramegna G; Scevola D; Michelone G
    Microbiologica; 1987 Apr; 10(2):189-96. PubMed ID: 3587067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [In vitro susceptibility of vaginal Candida albicans to antifungal drugs in Abidjan (Ivory Coast)].
    Djohan V; Angora KE; Vanga-Bosson AH; Konaté A; Kassi FK; Yavo W; Kiki-Barro PC; Menan H; Koné M
    J Mycol Med; 2012 Jun; 22(2):129-33. PubMed ID: 23518014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro antifungal resistance in Candida albicans from HIV-infected patients with and without oral candidosis.].
    Ceballos Salobreña A; Gaitán Cepeda LA; Orihuela Cañada F; Olea Barrionuevo D; Ceballos García L; Quindós G
    Rev Iberoam Micol; 1999 Dec; 16(4):194-7. PubMed ID: 18473546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A].
    Corelli F; Massa S; Stefancich G; Mai A; Artico M; Panico S; Simonetti N
    Farmaco Sci; 1987 Dec; 42(12):893-903. PubMed ID: 3329612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro activity of antifungal agents in combination with four quinolones.
    Petrou MA; Rogers TR
    Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antimycotic susceptibility testing of yeasts important in dermato-venereology: methods, results and clinical relevance].
    Korting HC; Georgii A
    Hautarzt; 1988 Jun; 39(6):343-7. PubMed ID: 3042703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics of a strain of C. albicans resistant to polyene antibiotics].
    Mikhaĭlova MA; Virina AM; Kravchenko TI
    Antibiotiki; 1979 Nov; 24(11):828-31. PubMed ID: 389154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.